Evaro

Series-A
evaro.com Biotech & Healthcare
Total Funding $25M
Latest Round $25M Series-A
Last Announced Oct 13, 2026
Investors Undisclosed
Decision Makers 2 Verified

About Evaro

Add prescription healthcare to your platform in days, not years. Complete healthcare integration with regulatory compliance, clinical oversight, and fulfilment.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 13, 2026

Web & Domain Identity

Official Website evaro.com
Domain Registered Date Jan 28, 2002

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $25,000,000 · Series-A

    thesaasnews.com

  2. Milestone

    Website domain registered

    evaro.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Evaro.

Funding History

1 Round
Series-A equity · Oct 13, 2026
$25,000,000 thesaasnews.com

Founders & Leadership

2

Oskar Wenbar

COO & Co-Founder

Work email & phone locked Unlock →

Thuria Wenbar

CEO & Co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts